Successful Treatment of Severe Hepatorenal Syndrome with Living Donor Liver TransplantationDEMIRBAS, Baha Tolga; PISKIN, Turgut; DAYANGAC, Murat et al.Hepato-gastroenterology. 2012, Vol 59, Num 119, pp 2305-2306, issn 0172-6390, 2 p.Article

Diagnostic value of serum cystatin C for evaluation of hepatorenal syndromeDEMIRTAS, Selda; BOZBAS, Aysun; AKBAY, Aysegül et al.Clinica chimica acta. 2001, Vol 311, Num 2, pp 81-89, issn 0009-8981Article

Terlipressin in Hepatorenal SyndromeMAZUR, Joseph E; COOPER, Tanna B; DASTA, Joseph F et al.The Annals of pharmacotherapy. 2011, Vol 45, Num 3, pp 380-387, issn 1060-0280, 8 p.Article

Hepatorenal syndromeDEMIRTAS, Selda; CAN, Murat; YARPUZLU, Aysegül et al.Clinical chemistry and laboratory medicine. 2006, Vol 44, Num 4, pp 379-386, issn 1434-6621, 8 p.Article

Syndrome hépatorénal : prévention et traitement = Hepatorenal syndrome : Prevention and treatmentGONZALEZ, F; VINCENT, F; COHEN, Y et al.Réanimation (Paris. 2001). 2007, Vol 16, Num 7-8, pp 605-611, issn 1624-0693, 7 p.Article

Splanchnic vasodilation and renal vasocnstriction : a key to the hepatorenal syndrome ?BOSCH, J.Hepatology (Baltimore, Md.). 1990, Vol 12, Num 6, pp 1445-1447, issn 0270-9139, 3 p.Article

Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control studyRESTUCCIA, Tea; ORTEGA, Rolando; RODES, Juan et al.Journal of hepatology. 2004, Vol 40, Num 1, pp 140-146, issn 0168-8278, 7 p.Article

Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndromeTESTRO, Adam G; WONGSEELASHOTE, Sarah; ANGUS, Peter W et al.Journal of gastroenterology and hepatology. 2008, Vol 23, Num 10, pp 1535-1540, issn 0815-9319, 6 p.Article

Terlipressin therapy for renal failure in cirrhosisTRIANTOS, Christos K; SAMONAKIS, Dimitrios; THALHEIMER, Ulrich et al.European journal of gastroenterology & hepatology. 2010, Vol 22, Num 4, pp 481-486, issn 0954-691X, 6 p.Article

Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-analysis of randomized controlled trialsSAGI, Sashidhar V; MITTAL, Sahil; KASTURI, Krishna S et al.Journal of gastroenterology and hepatology. 2010, Vol 25, Num 5, pp 880-885, issn 0815-9319, 6 p.Article

Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosisFAGUNDES, Claudia; PEPIN, Marie-Noëlle; POCH, Esteban et al.Journal of hepatology. 2012, Vol 57, Num 2, pp 267-273, issn 0168-8278, 7 p.Article

Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expressionSHAH, Naina; DHAR, Dipok; JALAN, Rajiv et al.Journal of hepatology. 2012, Vol 56, Num 5, pp 1047-1053, issn 0168-8278, 7 p.Article

The evaluation of renal function and disease in patients with cirrhosisFRANCOZ, Claire; GLOTZ, Denis; MOREAU, Richard et al.Journal of hepatology. 2010, Vol 52, Num 4, pp 605-613, issn 0168-8278, 9 p.Article

Octreotide in hepatorenal syndrome: A randomized, double-blind, placebo-controlled, crossover studyPOMIER-LAYRARGUES, Gilles; PAQUIN, Sarto C; HASSOUN, Ziad et al.Hepatology (Baltimore, Md.). 2003, Vol 38, Num 1, pp 238-243, issn 0270-9139, 6 p.Article

Hepatorenal syndromeLEVY, M.Kidney international. 1993, Vol 43, Num 3, pp 737-753, issn 0085-2538Conference Paper

Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrme : experience in 300 patientsGONWA, T. A; MORRIS, C. A; GOLDSTEIN, R. M et al.Transplantation. 1991, Vol 51, Num 2, pp 428-430, issn 0041-1337, 3 p.Conference Paper

Pathophysiology and treatment of ascites and the hepatorenal syndromeGENTILINI, P; LAFFI, G.Baillière's clinical gastroenterology. 1992, Vol 6, Num 3, pp 581-607, issn 0950-3528Article

Systemic and regional haemodynamics in pigs with acute liver failure and the effect of albumin dialysisYTREBO, Lars M; SEN, Sambit; JALAN, Rajiv et al.Scandinavian journal of gastroenterology. 2006, Vol 41, Num 11, pp 1350-1360, issn 0036-5521, 11 p.Article

Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascitesSERSTE, T; LEBREC, D; VALLA, D et al.Acta gastro-enterologica belgica (English ed.). 2008, Vol 71, Num 1, pp 9-14, issn 1784-3227, 6 p.Article

Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome : Transjugular intrahepatic portosystemic stent shuntsSENZOLO, Marco; CHOLONGITAS, Evangelos; TIBBALLS, Jonathan et al.European journal of gastroenterology & hepatology. 2006, Vol 18, Num 11, pp 1143-1150, issn 0954-691X, 8 p.Article

Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndromeSANER, Fuat H; FRÜHAUF, Nils R; SCHÄFERS, Rafael F et al.European journal of gastroenterology & hepatology. 2003, Vol 15, Num 8, pp 925-927, issn 0954-691X, 3 p.Article

Syndrome hépatorénal = Hepatorenal syndromePILLEBOUT, Evangéline.Néphrologie & thérapeutique. 2014, Vol 10, Num 1, pp 61-68, issn 1769-7255, 8 p.Article

The role of Duplex-Doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosisKASTELAN, Snjezana; LJUBICIC, Neven; KASTELAN, Zeljko et al.Hepato-gastroenterology. 2004, Vol 51, Num 59, pp 1408-1412, issn 0172-6390, 5 p.Article

Hepatorenal Syndrome: Do the Vasoconstrictors Work?LEUNG, Wesley; WONG, Florence.Gastroenterology clinics of North America. 2011, Vol 40, Num 3, issn 0889-8553, vi-vii, 581-598 [20 p.]Article

Systematic Review of Randomized Trials on Vasoconstrictor Drugs for Hepatorenal SyndromeGLUUD, Lise L; CHRISTENSEN, Kurt; CHRISTENSEN, Erik et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 2, pp 576-584, issn 0270-9139, 9 p.Article